至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The arrhythmogenic calmodulin p. Phe142Leu mutation impairs C-domain Ca2+ binding but not calmodulin-dependent inhibition of the cardiac ryanodine receptor

Journal of Biological Chemistry. 2016; 
Mads Toft Søndergaarda,b, Yingjie Liub, Kamilla Taunsig Larsena, Alma Nanid, Xixi Tianb, Christian Holta, Ruiwu Wangb, Reinhard Wimmera, Filip Van Petegemc, Michael Filld, S.R. Wayne Chenb,d and Michael Toft Overgaarda,
Products/Services Used Details Operation
Peptide Synthesis Isothermal titration calorimetry of RyR2(R3581-P3607) peptide with CaM - A peptide corresponding to the CaMBD (human RyR2 3581- RSKKAVWHKLLSKQRKRAVVACFRMAP-3607) was purchased from GenScript (Piscataway, USA) at > 95 % purity. Titration of the RyR2(R3581-L3607) peptide with CaMs was investigated under both Ca2+ free (apo) and Ca2+ saturating condition and followed using ITC. Purified CaM variants were dialyzed (10 K Slide-a-lyzerTM, Thermo Scientific) against the titration buffer (10 mM HEPES, 150 mM KCl, pH 7.2) with either 10 mM EDTA or 10 mM CaCl2 added for 40 h at 4 o C (with buffer changed at 24 h). Get A Quote

摘要

A number of point mutations in the intracellular Ca2+-sensing protein calmodulin (CaM) are arrhythmogenic, yet their underlying mechanisms are not clear. These mutations generally decrease Ca2+ binding to CaM and impair inhibition of CaMregulated Ca2+ channels like the cardiac Ca2+- release channel (ryanodine receptor, RyR2), and it appears that attenuated CaM Ca2+-binding correlates with impaired CaM-dependent RyR2 inhibition. Here, we investigated the RyR2 inhibitory action of the CaM p.Phe142Leu mutation (F142L; numbered including the start-Met), which markedly reduces CaM Ca2+-binding. Surprisingly, CaM-F142L had little to no aberrant effect on RyR2-mediated store-overload induced Ca2+- release in HEK293 ce... More

关键词

Calmodulin, arrhythmia, cardiac ryanodine receptor, intracellular Ca2+-release, CaM-F142L